title: Design and synthesis of novel thiazole-containing cross-linked polyamides related to the antiviral antibiotic distamycin.
abstract: A family of naturally occurring oligopeptides includes netropsin, distamycin, anthelvencin, kikumycin B, amidinomycin, and norformycin. Netropsin (I) and distamycin (II) express their biological activities by targeting specific sequences of chemical functionalities in the minor groove of DNA. Both netropsin and distamycin can be regarded as polyamide chains in which each alpha-carbon has been replaced by a five-membered pyrrole ring. The repeat distance in such an augmented polyamide chain is almost the same as the distance from one base pair to the next along the floor of a minor groove within beta-DNA. In this paper we report the synthesis of 16-21 cross-linked polyamides containing a thiazole heterocyclic ring bearing the active functionalites NH(2), NHCHO, or H. 16 and 17 were synthesized by DCC and HOBt catalyzed reaction of 5 with 14 and 15, while the formylation products 18 and 19 were obtained by coupling the formylated 4-methyl-thiazolated acid 6 with 14 and 15. The deaminated compounds 20 and 21 were obtained by the coupling of 5-trichloroacetyl-4-methylthiazole 7 synthesized from 4-methylthiazole. All the six cross-linked polyamides 16-21 were tested for their DNA gyrase inhibition. The studies have shown these polyamides have better sequence recognition and a greater percentage of inhibition than the corresponding monomers. The compound 17 shows complete inhibition of gyrase at 0.5 microM concentration as compared to the naturally occurring distamycin at 1.0 microM.
authors.affiliation: Department of Chemistry, University Of Alberta, Edmonton, Alberta, Canada T6G 2G2.
authors.forename: S K
authors.initials: SK
authors.lastname: Sharma
authors.forename: M
authors.initials: M
authors.lastname: Tandon
authors.forename: J W
authors.initials: JW
authors.lastname: Lown
mesh_terms: D000998:Antiviral Agents / Q000138:chemical synthesis* / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D004247:DNA / Q000378:metabolism; D004250:DNA Topoisomerases, Type II / Q000378:metabolism; D004214:Distamycins / Q000737:chemistry* / Q000494:pharmacology; D009682:Magnetic Resonance Spectroscopy; D013058:Mass Spectrometry; D009757:Nylons / Q000138:chemical synthesis* / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D009842:Oligopeptides / Q000737:chemistry / Q000494:pharmacology; D011758:Pyrroles / Q000737:chemistry / Q000378:metabolism; D013844:Thiazoles / Q000737:chemistry* / Q000378:metabolism; D059005:Topoisomerase II Inhibitors
chemical_list: D000998:Antiviral Agents; D004214:Distamycins; D009757:Nylons; D009842:Oligopeptides; D011758:Pyrroles; D013844:Thiazoles; D059005:Topoisomerase II Inhibitors; C030000:stallimycin; D004247:DNA; D004250:DNA Topoisomerases, Type II